Lead Optimization is an important technique in new drug development. It encompasses several fields such as synthetic chemistry, phytochemistry, analysis, pharmacology and microbiology.
PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENTShikha Popali
THE PHARMACOPHORE MAPPING AND VIRTUAL SCRRENING , THESE PRESENTATION INCLUDES THE DEATIL ACCOUNT ON PHARMACOPHORE, MAPPING, ITS IDENTIFIATION FEATURES, ITS CONFORMATIONAL SEARCH, INSILICO DRUG DESIGN, VIRTUAL SCREENING, PHARMACOPHORE BASED SCREENING
PHARMACOHORE MAPPING AND VIRTUAL SCRRENING FOR RESEARCH DEPARTMENTShikha Popali
THE PHARMACOPHORE MAPPING AND VIRTUAL SCRRENING , THESE PRESENTATION INCLUDES THE DEATIL ACCOUNT ON PHARMACOPHORE, MAPPING, ITS IDENTIFIATION FEATURES, ITS CONFORMATIONAL SEARCH, INSILICO DRUG DESIGN, VIRTUAL SCREENING, PHARMACOPHORE BASED SCREENING
The basic aspects of drug discovery starts from target discovery and validation further going to lead identification and optimization. In this particular slide discussion is regarding the target discovery and the tools that have been utilized in this process.
SAR versus QSAR, History and development of QSAR, Types of physicochemical
parameters, experimental and theoretical approaches for the determination of
physicochemical parameters such as Partition coefficient, Hammet’s substituent
constant and Taft’s steric constant. Hansch analysis, Free Wilson analysis, 3D-QSAR
approaches like COMFA and COMSIA.
Role of Target Identification and Target Validation in Drug Discovery ProcessPallavi Duggal
Target identification and Validation tells about the how target is neccesary for new drug discovery and its development to reach into market for rare diseases.
Target Validation
Introduction,Drug discovery, Target identification and validation, Target validation and techniques
By
Ms. B. Mary Vishali
Department of Pharmacology
ABSTRACT- L-Ascorbic acid derivatives was synthesized on treatment with acetone and acetyl chloride afforded 5,6-acetal of L-ascorbic acid then benzylation of C-2 and C-3 hydroxyl groups of the lactone ring was accomplished using K2CO3 and benzyl bromide in DMF, then deblocking of the 5,6-O,O-protected derivative of L-Ascorbic acid with acetic acid and methanol gave 2,3-O,O-dibenzyl-L-Ascorbic acid. Subsequently mono-tosylation at 6 position of 2,3-O, O-dibenzyl-L-Ascorbic acid was carried out with addition of p-toluenetosylchloride (PTSC) in Pyridine and MDC solvent medium gave 2,3-O,O-dibenzyl-6-O-tosyl-L-Ascorbic acid. All the structures were characterized by 1H NMR, 13C NMR and Mass Spectroscopy.
Key-words- L-Ascorbic acid, 5,6-Acetal, Benzylation, Hydrolysis, Tosylation
The basic aspects of drug discovery starts from target discovery and validation further going to lead identification and optimization. In this particular slide discussion is regarding the target discovery and the tools that have been utilized in this process.
SAR versus QSAR, History and development of QSAR, Types of physicochemical
parameters, experimental and theoretical approaches for the determination of
physicochemical parameters such as Partition coefficient, Hammet’s substituent
constant and Taft’s steric constant. Hansch analysis, Free Wilson analysis, 3D-QSAR
approaches like COMFA and COMSIA.
Role of Target Identification and Target Validation in Drug Discovery ProcessPallavi Duggal
Target identification and Validation tells about the how target is neccesary for new drug discovery and its development to reach into market for rare diseases.
Target Validation
Introduction,Drug discovery, Target identification and validation, Target validation and techniques
By
Ms. B. Mary Vishali
Department of Pharmacology
ABSTRACT- L-Ascorbic acid derivatives was synthesized on treatment with acetone and acetyl chloride afforded 5,6-acetal of L-ascorbic acid then benzylation of C-2 and C-3 hydroxyl groups of the lactone ring was accomplished using K2CO3 and benzyl bromide in DMF, then deblocking of the 5,6-O,O-protected derivative of L-Ascorbic acid with acetic acid and methanol gave 2,3-O,O-dibenzyl-L-Ascorbic acid. Subsequently mono-tosylation at 6 position of 2,3-O, O-dibenzyl-L-Ascorbic acid was carried out with addition of p-toluenetosylchloride (PTSC) in Pyridine and MDC solvent medium gave 2,3-O,O-dibenzyl-6-O-tosyl-L-Ascorbic acid. All the structures were characterized by 1H NMR, 13C NMR and Mass Spectroscopy.
Key-words- L-Ascorbic acid, 5,6-Acetal, Benzylation, Hydrolysis, Tosylation
ER Publication,
IJETR, IJMCTR,
Journals,
International Journals,
High Impact Journals,
Monthly Journal,
Good quality Journals,
Research,
Research Papers,
Research Article,
Free Journals, Open access Journals,
erpublication.org,
Engineering Journal,
Science Journals,
An Efficient Synthetic Approach Towards 4-Cyano-3-(Methylthio)-5-Oxo-2H-Pyraz...inventionjournals
ABSTRACT: Synthesis of novel heterocyclic 4-cyano -3-(methylthio)-5-oxo-2H-pyrazole-1(5H)- carbothioamide (3) was prepared by condensing ethyl-2-cyano-3,3-bis (methylthio)acrylate (1) with thiosemicarbazide (2) in DMF and catalytic amount of potassium carbonate. Compound (3) has methylthio group at third position, which is replaced by different nucleophiles such as substituted anilines| phenols| hetryl amines| compounds containing active methylene group to afford 3-substituted derivatives of compound (3). All the newly synthesized compounds were screened for their antimicrobial activity.
Synthesis, characterization, in vitro cytotoxic and antioxidant activities of...ijperSS
ABSTRACT
A series of novel (Z)-3-(2-(4-(2-oxo-2H-chromen-3-yl) thiazol-2-yl-)hydrazono)indolin-2-one (8a-8d, 9) were synthesized with various substituted indole derivatives. Structures of the newly synthesized compounds were elucidated by FT-IR, 1H-NMR, 13C-NMR and API-ES Mass spectral data. The in vitro cytotoxic activities of the complexes measurement against the human cancer T-lymphocyte cell lines. In vitro evaluation of these title complexes revealed cytotoxicity from 6.8-18µg/mL against CEM, 9.2-21µg/mL against L1210, 10-19µg/mL against Molt4/C8, 8-12µg/mL against HL60 and 8-16µg/mL against BEL7402. Coumarin derivatives 8c and 8d showed that quite significant anticancer activities. The antioxidant activity of the synthesized compounds was evaluated by DPPH scavenging method. Compounds 8c, 8d and 9 showed significant antioxidant activity compared with that of standard drug, ascorbic acid.
Key words: Coumarin, DPPH, Cytotoxic activity.
Si-Imidazole-HSO4 Functionalized Magnetic Fe3O4 Nanoparticles as an Efficient...Iranian Chemical Society
An efficient and simple method for the preparation of Si-Imidazole-HSO4 functionalized magnetic Fe3O4 nanoparticles (Si-Im-HSO4 MNPs) and used as an efficient and reusable magnetic catalysts for the regioselective ring opening of epoxides under green conditions in water. This catalyst was used for the ring opening of epoxide corresponding to the thiocyanohydrins and azidohydrines. Compared to the classical ring opening of epoxides, this new method consistently has the advantage of excellent yields, short reaction times, and methodological simplicity.
New Schiff base ligand (E)-6-(2-(4-
(dimethylamino)benzylideneamino)-2-phenylacetamido)-3,3-
dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic
acid = (HL) Figure(1) was prepared via condensation of
Ampicillin and 4(dimethylamino)benzaldehyde in methanol
.Polydentate mixed ligand complexes were obtained from 1:1:2
molar ratio reactions with metal ions and HL, 2NA on reaction
with MCl2 .nH2O salt yields complexes corresponding to the
formulas [M(L)(NA)2Cl] ,where M =
Fe(II),Co(II),Ni(II),Cu(II),and Zn(II) and NA=nicotinamide.
The 1H-NMR, FT-IR, UV-Vis and elemental analysis
were used for the characterization of the ligand. The complexes
were structurally studied through AAS, FT-IR, UV-Vis,
chloride contents, conductance, and magnetic susceptibility
measurements. All complexes are non-electrolytes in DMSO
solution. Octahedral geometries have been suggested for each
of the complexes. The Schiff base ligands function as
tridentates and the deprotonated enolic form is preferred for
coordination. In order to evaluate the effect of the bactericidal
activity, these synthesized complexes, in comparison to the un
complexed Schiff base has been screened against bacterial
species, Staphy
A new Schiff base 4-chlorophenyl)methanimine
(6R,7R)-3-methyl-8-oxo-7-(2-phenylpropanamido)-5-thia-1-
azabicyclo[4.2.0]oct-2-ene-2-carboxylate= (HL)= C23H20
ClN3O4S) has been synthesized from β-lactam antibiotic
(cephalexin mono hydrate(CephH)=(C16H19N3O5S.H2O) and 4-
chlorobenzaldehyde . Figure(1) Metal mixed ligand complexes
of the Schiff base were prepared from chloride salt of
Fe(II),Co(II),Ni(II),Cu(II),Zn(II) and Cd (II), in 50% (v/v)
ethanol –water medium (SacH ) .in aqueous ethanol(1:1)
containing and Saccharin(C7H5NO3S) = sodium hydroxide.
Several physical tools in particular; IR, CHN, 1H NMR, 13C
NMR for ligand and melting point molar conductance, magnetic
moment. and determination the percentage of the metal in the
complexes by flame(AAS). The ligands and there metal
complexes were screened for their antimicrobial activity against
four bacteria (gram + ve) and (gram -ve) {Escherichia coli,
Pseudomonas aeruginosa, Staphylococcus aureus and Bacillus}.
The proposed structure of the complexes using program, Chem
office 3D(2006). The general formula have been given for the
prepared mixed ligand complexes Na2[M(Sac)3(L)], M(II) = Fe
(II), Co(II) , Ni(II), Cu (II), Zn(II) , and Cd(II).
HL= C29H24 ClN3O4S, L= C29H23 ClN3O4S -.
A STUDY TO EVALUATE THE IN VITRO ANTIMICROBIAL ACTIVITY AND ANTIANDROGENIC E...Dr. Pradeep mitharwal
The present paper deals with synthesis and characterization
of some new chromium (III) Schiff base complexes using microwave irradiation
technique as well as conventional heating. The S∩N donor benzothiazolines, 1-
(2-furanyl) ethanone benzothiazoline (Bzt1N
∩
SH), 1-(2-thienyl) ethanone
benzothiazoline (Bzt2N
∩
SH) and 1-(2-pyridyl) ethanone benzothiazoline
(Bzt3N
∩
SH) were prepared by the condensation of ortho-aminothiophenol with
respective ketones in ethanol.
International Journal of Pharmaceutical Science Invention (IJPSI) is an international journal intended for professionals and researchers in all fields of Pahrmaceutical Science. IJPSI publishes research articles and reviews within the whole field Pharmacy and Pharmaceutical Science, new teaching methods, assessment, validation and the impact of new technologies and it will continue to provide information on the latest trends and developments in this ever-expanding subject. The publications of papers are selected through double peer reviewed to ensure originality, relevance, and readability. The articles published in our journal can be accessed online.
Synthesis, spectroscopic, magnetic properties and superoxide dismutase (SOD) ...IOSR Journals
Three new ternary copper(II) complexes formulated as [Cu(HIda)(bipy)] 1; [Cu(HIda)(phen)] 2; [Cu(HIda)(dmp)] 3; where HIda =N-(2-hydroxyethyl)-2- iminodiacetic acid ; bipy = 2, 2’- bipyridine; phen = 1,10- phenanthroline; dmp = 2,9-dimethyl 1,10-phenanthroline, have been synthesized and characterized by partial elemental analysis, FAB-mass (m/z), EPR, UV-visible and CV measurements. The magnetic and spectroscopic data of all these complexes 1-3 indicate distorted octahedral geometry. The EPR spectra of these complexes in frozen DMSO solutions showed a single at g ca. 2. The trend in g-value (g||>g>2.0023) suggests that the unpaired electron on copper (II) has dx2–y2 character. The SOD activities of the complexes have been investigated. Antibacterial and antifungal activity of these complexes were also measured and discussed.
Similar to Lead Optimization in Drug Discovery (20)
Unit 8 - Information and Communication Technology (Paper I).pdfThiyagu K
This slides describes the basic concepts of ICT, basics of Email, Emerging Technology and Digital Initiatives in Education. This presentations aligns with the UGC Paper I syllabus.
Synthetic Fiber Construction in lab .pptxPavel ( NSTU)
Synthetic fiber production is a fascinating and complex field that blends chemistry, engineering, and environmental science. By understanding these aspects, students can gain a comprehensive view of synthetic fiber production, its impact on society and the environment, and the potential for future innovations. Synthetic fibers play a crucial role in modern society, impacting various aspects of daily life, industry, and the environment. ynthetic fibers are integral to modern life, offering a range of benefits from cost-effectiveness and versatility to innovative applications and performance characteristics. While they pose environmental challenges, ongoing research and development aim to create more sustainable and eco-friendly alternatives. Understanding the importance of synthetic fibers helps in appreciating their role in the economy, industry, and daily life, while also emphasizing the need for sustainable practices and innovation.
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdfTechSoup
In this webinar you will learn how your organization can access TechSoup's wide variety of product discount and donation programs. From hardware to software, we'll give you a tour of the tools available to help your nonprofit with productivity, collaboration, financial management, donor tracking, security, and more.
Read| The latest issue of The Challenger is here! We are thrilled to announce that our school paper has qualified for the NATIONAL SCHOOLS PRESS CONFERENCE (NSPC) 2024. Thank you for your unwavering support and trust. Dive into the stories that made us stand out!
We all have good and bad thoughts from time to time and situation to situation. We are bombarded daily with spiraling thoughts(both negative and positive) creating all-consuming feel , making us difficult to manage with associated suffering. Good thoughts are like our Mob Signal (Positive thought) amidst noise(negative thought) in the atmosphere. Negative thoughts like noise outweigh positive thoughts. These thoughts often create unwanted confusion, trouble, stress and frustration in our mind as well as chaos in our physical world. Negative thoughts are also known as “distorted thinking”.
1. Prof. A. S. Dhake
Professor,
S.M.B.T. College of Pharmacy
Dhamangaon, Nashik (Maharashtra)
Web. : www.smbt.edu.in
2.
3.
4.
5. Lead Compound – A prototype compound which has the desired biological activity, but
may have other undesirable characteristics.
Drug discovery without a lead –
Penicillin G – Discovered by Alexander Fleming in 1928. Penicillium notatum inhibited
the growth of Staphylococcus aureus.
Bioassay – A prerequisite for drug discovery studies.
6. I) From Known Active Compounds:
A) Compounds naturally regulating functions –
(Hormones/ neurotransmitters)
Norepinephrine (NE) – lead for sympathetic agonists and antagonists.
O
H
O
H
NH2
OH
NE
O
H
O
H
NH
OH
CH3
C
H3
Isoproterenol ( agonist)
O
H
NH
OH
CH3
C
H3
O
H
CH3
Salbutamol ( agonist)
β
β2
7. B) Therapeutically used drugs:
a) Active principles from medicinal plants-
I)
Cocaine Procaine
Cocaine – alkaloid from Erythroxylon coca
.
O
N CH3
N
H2
OCH 2CH2NEt 2
O
O
b) Clinical observation of side effects –
i) Sulphonamides Antidiabetic sulphonyl ureas
8. C) Drug Metabolism Studies –
Metabolites are isolated and screened. Active metabolite may serve as a
lead.
II) Generation Of New Leads:
A) Biomolecular processes (Rational Approach) – If disease process
is known, drug can be designed on the basis of structure of agonists
or of receptors or enzymes.
9. Cancer Therapy –
Substances required for the rapid growth of cancer cells serve as leads.
Lead Structure Anticancer Drug
Pyrimidine nucleus - 5 – fluoro uracil
Purine nucleus - 6 – mercaptopurine
Folic acid - Methotrexate, aminopterine
B) Random Screening –
Screen of soil samples for antibiotics –
Streptomycin and tetracyclines.
Random screen for anticancer drugs –
National Cancer Institute.
10. Structural variation of the lead to obtain a drug with desired profile.
Objectives of molecular manipulation –
1. To develop substitutes for existing bioactive compounds eg. Hormones, vitamins,
neurotransmitters..
2. To change the spectrum of activity of lead –
a) To obtain antagonists from agonists.
b) To separate activities -
Androgenic steroids Anabolic steroids.
Sulphonamides Antidiabetics; diuretics.
c) To combine action of different drugs -
Action of oxytocin + vasopressin Oxypressin.
d) To eliminate side effects –
Glucocorticoids: Cortisone Prednisone Dexamethasone
Mineralocorticoid activity: 0.8 0.6 0
e) To obtain species/organ selectivity in action - selective blockade of DHF
reductase from tumour cells.
11. 3. To modulate the pharmacokinetics of lead –
a) To decrease sensitivity to degrading enzymes-
Acetylcholine Methacholine
Penicillins
b) To modify time – conc. Relationship –
Steroid hormone esters –
Depot preparation – dexycortisone acetate
I.v. therapy – hydrocortisone sodium succinate
c) To modify drug distribution –
Methylatropine – quaternary compound, no CNS activity.
Sulphonamides for treatment of intestinal infections – phthalylsulphacetamide.
12. Identification of pharmacophore –
Morphine Pharmacophore for narcotic analgesic.
A) Non computational methods
a) Functional group optimization –
Substituents required for maximal activity can be predicted.
Carbutamide Tolbutamide
(Antibacterial) (Antidiabetic)
N
O
OH OH
CH3
C
CH2
CH2
N
C
H3 SO2
NH
NH
O
n - Bu
N
H2 SO2
NH
NH
O
n - Bu
14. b) Structure – Activity Relationships (SAR) –
Activities of series of compounds are interpreted in terms of structural features.
Sulphonamides show three major activities.
General Structures –
NH
R1
R SO2NH C
X
Antidiabetic
H2N SO2NHR Antibacterial
N
S
O2
NH
R2
S
O2
H2N
R1
Diuretic
15. c) Homologation –
Homologous series – compounds differ by a constant unit, C
In – n – alcohols – max. hypnotic activity seen from 1 – hexanol to 1 – octanol.
In 4 – n – alklyresorsinols – max. antibacterial activity seen for 4 - n –
hexylresorsinol.
Balance of hydrophilic – lipophilic nature is important.
16. d) Bioisosterism –
Bioisosteres – groups which have similar physical and chemical properties and hence
give a similar pattern of biological activity.
Grimm – Hydride displacement law (1925)
Classical isosteres - -CH3, - NH2, -OH, -F, -Cl.
Ring equivalents – benzene, pyridine
Nonclassical isosteres - -COOH, -SO3H, -SO2
Antihistamines –
Ar
Ar1
X CH2 CH2 N
CH O
N
CH
X Class
Aminoalkylethers
Ethylenediamines
Propylamines
Examples
Diphenhydramine
Pyrilamine
Chlorpheniramine
17. Development of Procainamide –
H2N
O
O
CH2CH2NEt2
H2N
O
NH
CH2CH2NEt2
Procaine (Local anaesthetic)
Procainamide (Antiarrhythmic)
18. e) Chain branching –
S
N
R
Phenothiazines
R
-CH2CH2CH2N(CH 3)2
-CH2CH(CH 3)N(CH 3)2
-CH2CH(CH 3)CH2N(CH 3)2
Drug
Promazine
Promethazine
Trimeprazine
Major activity
Tranquilizer
Antihistaminic
Antipruritic
19. f) Ring – chain transformation
Trimeprazine and methdilazine have similar antipruritic activity.
Amphetamine Tranylcypromine
CNS Stimulant Antidepressant
g) Conversion of natural products –
Competitive antagonists may be developed from structures of agonist molecules.
R
CH2 CH
CH2
CH2
CH2
N CH3
Methdilazine
Ph CH2 CH NH2
CH3
Ph CH CH NH2
CH2
20. i - Bu
COOH
CH3
Ibuprofen
(in acid chloride form)
N
H2 R
R = H Aniline
R = OMe p - Anisidine
R = OH p - Aminophenol
i - Bu
C
H3
O
NH
R
h) Formation of twin compounds-
Two drug molecules are combined by covalent binding.
2 Quinine Diquinine carbonate
2 Salicylic acid Salicyl salicylate
Twins of ibuprofen
The twin drugs were tested for analgesic and anti-inflammatory activity.
21. i) Microbial Transformations –
Microorganisms supplied with suitable, unnatural precursors, can
synthesize new chemical analogs of the natural product. Penicillium
mould supplied with phenoxy acetic acid Phenoxymethyl
penicillin (penicillin V).
Similar synthesis using Br – ions – bromotetracycline,
bromogriseofulvin.
22. a) Quantitative Structure – Activity Relationships (QSAR)
Biological activity is a function of physicochemical properties. Parameters based
on – Lipophilicity – log P, , Rm.
Electronic effects – , I, *, F, R, pKa,
Steric effects – Es, rv, X, MR, MSD, P.
Rb = f(P). kx
Hansch Analysis –
log (1/C) = k1 (log P)2 + k2 log P + k3 b + k4 Es + k5
B) Computational methods
23. QSAR modeling and data analysis facilities
2D QSAR
• Rapid calculation of 2000+ descriptors including
2D, 3D, alignment independent & interaction
descriptors.
•Applicability domain check
•AutoQSAR for multiple model building
3D QSAR
•Novel molecular field analysis based on kNN
method (kNN MFA)
•Molecular field descriptors with biological
activity
•Consideration of non-linear relationships between
activity and descriptors using kNN MFA
•Contour visualization with PLS MFA
•AutoQSAR for multiple model building
24. Data preprocessing
• Graphical representation of relative distribution of descriptor values by
distribution and pattern plot
• Univariate analysis of descriptors
• Cross correlation matrix to investigate the relationship between different
descriptors
Data processing
• Multiple response QSAR modeling
• Training and test set selection methods: Manual, Sphere Exclusion,
Random
25. Pharmacophore identification and modeling
• Features such as H-bond donor, H-bond acceptor, positive charge,
negative charge and hydrophobe
• Application of conformer flexibility of molecules for generation of
several pharmacophore hypotheses
•Pattern search for 3 point, 4 point, 5 point and upto n-point
pharmacophore identification with RMSD & distance
• Generation of automated query for 3D database searches through
integration with ChemDBS
26. Virtual combinatorial library generation
•Ability to define multiple sites for substitution
•ADME screen based on extended Lipinski's rule
•Predicting activity of virtually generated library of
molecules through QSARPlus
•Applicability domain check on generated library model
•GRIP docking based screening
•kNN MFA model based optimization and screening
27. 3D Property Visualization & Evaluation
• Calculation and visualization of wide variety of Quantum Mechanical
properties including ED, MESP, EMD, ELF, AIE
• Calculation of molecular surface area , hydrophobicity, charge based ESP
• Moments of charge distribution, Mulliken population analysis, HOMO, LUMO
28. Efficient searches for compound databases
• Comprehensive Database Creation and Management
• Comprehensive search criteria: 2D/3D substructure, similarity or descriptor based
• Advanced molecular fingerprint and Pharmacophore based searches
• Comprehensive search criteria
29. Residue
(Trimyristin)
Crude oil
Evaporation
Crushed nutmeg
Chloroform extract
Residue
Precipitation of Trimyristin
Myristic acid
Filtrate
Myristicin
Reflux for CHCl3 for 10 hr.
Dissolved in ethanol and cooled in ice
1. Alc. KOH
2. Con. HCl
Distillation
Col. Chrom.
Ikan, R.. In Natural Products – A Laboratory Guide;
Academic Press, New York; 1969: pp. 25, 30
33. QSAR studies of Myristic acid derivatives
v Training and prediction tests
v Calculation of molecular descriptors – CAChe
Pro 6.0 for Windows
v Construction of correlation matrix
v MLR analysis & “LOO” approach
v Prediction of activity based on best MLR model
v Comparison of observed and calculated activity
42. QSAR model for antibacterial activity against E. coli
-logMIC = 0.061 0v + 1.635 (1)
n =20 r = 0.963 F = 232.661 s = 0.027 r2
cv = 0.902
QSAR model for antibacterial activity against S. aureus
-logMIC = 0.217 2v + 1.375 (2)
n =20 r = 0.978 F = 407.85 s = 0.030 r2
cv = 0.931
QSAR model for antibacterial activity against M. luteus
-logMIC = 0.229 2v + 1.268 (3)
n =20 r = 0.934 F = 123.968 s = 0.064 r2
cv = 0.810
Balasubramanian Narasimhan, Vishnukant Mourya and Avinash
Dhake, Design, Synthesis, Antibacterial and QSAR Studies of
Myristic acid Derivatives, Bioorganic and Medicinal Chemistry
Letters, 16, 2006, 3023 - 3029
46. Antifungal activity against C. albicans (Eq.1)
-logMIC = 0.174 log P + 1.569 (1)
n =20 r = 0.940 q2 = 0.863 F = 137.85 s = 0.057
Antifungal activity against A. niger (Eq. 2)
-logMIC = -0.079 LUMO + 2.569 (2)
n =20 r = 0.924 q2 = 0.828 F = 106.17 s = 0.023
Antibacterial activity against P. aeruginosa (Eq. 3)
-logMIC = 1.036 3v + 2.429 (3)
n =20 r = 0.756 q2 = 0.484 F = 24.03 s = 0.122
Antibacterial activity against P. aeruginosa (Eq. 4)
-logMIC = 0.007 MR + 0.881 3v + 1.815 (4)
n =20 r = 0.854 q2 = 0.655 F = 22.97 s = 0.099
47. Antibacterial activity against B. subtilis (Eq. 5 & 6)
-log MIC = 0.113 0v + 1.077 (5)
n =20 r = 0.917 F = 95.65 s = 0.079 q2 = 0.808
-log MIC = 0.244 2v + 1.187 (6)
n =20 r = 0.908 F = 85.10 s = 0.083 q2 = 0.796
B. Narasimhan and A.S.Dhake, Theoretical modeling of antimicrobial activity of
myristic acid derivatives by Hansch analysis, National symposium on challenges in drug
discovery research: Networking opportunities between academia and Industries, Birla
Institute of Technology and Science, Pilani, April 7-8, 2006, P.93 [Abstract No. CC-902].
48. Termination of Search -
For each new drug developed –
No. of compounds synthesized ~ 10,000
Time required 15 Years
Cost ~ $ 800-850 million
When optimum profile is reached, search may be terminated.
49. Histamine 5-Methylhistamine
H2 agonist
H1 receptor – allergic and hypersensitivity reactions.
H2 receptor – stimulation of gastric acid secretion.
H2 antagonist may be useful in gastric and duodenal ulcers. Smith Kline & French
Laboratories, UK, initiated search for lead compound in 1964.α
Later, this lead and its analogs were found to be partial agonists. This was attributed to
protonation of side chain.
N
H N
NH NH2
NH
III
N - Guanyl histam
ine
(Lead)
α
N
H N
NH2
I II
N
H N
NH2
C
H3
50. Thiourea analog (First H2 antagonist)
Weak antagonist activity, no agonist activity.
Increase in chain length to 4 C gave pure competitive antagonist. N – Methyl analog –
Burimamide
First H2 antagonist tested in humans. Poor oral potency.
N NH
NH NHMe
S
V
N
H N
NH NH2
S
IV
51. 1, 3 – prototropic tautomerism in histamine and related compounds.
N – H tautomer is favoured by –
I) e- - withdrawing side chain
CH2 – S – CH2 - CH2 Thiaburimamide. VI
II) e- - releasing group at C5 –
~ 9 times more potent than Burimamide. Side effect – granulocytopenia; associated with thiourea group.
N
H N
C
H3
S
NH NHCH 3
S
VII
Metiamide
N NH
R
HN N
R
N - H Tautomer
Less active
N - H Tautomer
More active
π π
π
52. Isosteric replacement of Thiourea group
Analogs were 20 times less potent than X=S. To remove guanidine basicity, the N was
substituted with e- withdrawing groups – CN, NO2.
X = NCN, X = NNO2
Both compounds were potent H2 antagonists; X = NCN being more potent.
Cimetidine
Marketed in U. K. in 1976.
Later, ranitidine was introduced by Glaxo Labs.
NH2
N
H2
X
X = S Thiourea
X = O Urea
X = NH Guanidine
N
H N
C
H3
S
NH NHMe
NCN
VIII
53. 1. Silverman R. B. : The Organic Chemistry of Drug Design and Drug Action;
Academic
Press, San Diego, 7 – 105 (2004).
2. Ariens E. J. (Ed.) : Drug Design, Vol. X, Academic Press, New York, 1 – 69 (1980).
3. Kulkarni V. M. and Bothara K. G. : Drug Design, Nirali Prakashan, Pune, 1 – 22
(1995).
4. Testa B., Kyburz E., Fuhrer W. and Giger R. (Eds.) : Perspectives in Medicinal
Chemistry, VCH, Weinheim, 475 – 531 (1993).
5. Wolff M. E. (Ed.) : Burger’s Medicinal Chemistry and Drug Discovery, Vol. I :
Principles and Practice, John Wiley & Sons, New York, 1 – 8, 497 – 571, 983 –
1033 (2003).
6. Hansch C., Sammes P. G. and Taylor J. B. (Eds.) : Comprehensive Medicinal
Chemistry Vol. 1 – General Principles, 261 – 278, Vol. 4 – Quantitative Drug
Design, 1 – 31, 497 – 560, Pergamon Press, Oxford (1990).
7. Krogsgaard – Larsen P., Liljefors T. & Madsen U. (Eds) : Textbook of Drug Design
and Discovery, 117-155 (2002)
Selected References: